Disease-free survival as a surrogate for overall survival in patients with HER2-positive, early breast cancer in trials of adjuvant trastuzumab for up to 1 year: a systematic review and meta-analysis - The
PLOS ONE: High ECT2 expression is an independent prognostic factor for poor overall survival and recurrence-free survival in non-small cell lung adenocarcinoma
Clinical Trial Endpoints in Cancer Research: Four Terms You Should Know
Carboxyl-Terminal Modulator Protein Positively Acts as an Oncogenic Driver in Head and Neck Squamous Cell Carcinoma via Regulating Akt phosphorylation | Scientific Reports
Definition of progression free survival and overall survival for the... | Download Scientific Diagram
VisualAbstract: Effect of Laparoscopic vs Open Distal Gastrectomy on 3-Year Disease-Free Survival in Patients With Locally Advanced Gastric Cancer | 2 Minute Medicine
Disease-Free Survival As a Clinical Trial Endpoint: Does It Matter, and to Whom?
Long-term survival effect of the interval between mastectomy and radio | CMAR
Relationship between Progression-free Survival and Overall Survival in Randomized Clinical Trials of Targeted and Biologic Agents in Oncology
Frontiers | Disease-Free Survival at 2 and 3 Years is a Significant Early Surrogate Marker Predicting the 5-Year Overall Survival in Patients Treated with Radical Cystectomy for Urothelial Carcinoma of the Bladder:
Relationship between Progression-free Survival and Overall Survival in Randomized Clinical Trials of Targeted and Biologic Agents in Oncology
The value of progression-free survival to patients with advanced-stage cancer | Semantic Scholar
Multimodality management of gallbladder cancer can lead to a better outcome: Experience from a tertiary care oncology centre in North India
Kaplan-Meier survival curves for disease-free survival and overall... | Download Scientific Diagram
Ovarian stimulation for oocyte vitrification does not modify disease-free survival and overall survival rates in patients with early breast cancer - Reproductive BioMedicine Online
View Image
Kaplan-Meier Estimates of Disease-free Survival and Overall Survival in... | Download Scientific Diagram
Disease Free Survival - an overview | ScienceDirect Topics
Overall survival (a) and disease-free survival (b) among the entire... | Download Scientific Diagram
![PDF] Expression of KLF5 is a Prognostic Factor for Disease-Free Survival and Overall Survival in Patients with Breast Cancer | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/54299cb7a5bb25860c06f989601d90c07b81bf18/4-Figure2-1.png "PDF] Expression of KLF5 is a Prognostic Factor for Disease-Free Survival and Overall Survival in Patients with Breast Cancer | Semantic Scholar")
PDF] Expression of KLF5 is a Prognostic Factor for Disease-Free Survival and Overall Survival in Patients with Breast Cancer | Semantic Scholar
Disease-free survival as a surrogate for overall survival in patients with HER2-positive, early breast cancer in trials of adjuvant trastuzumab for up to 1 year: a systematic review and meta-analysis - The
Estimating progression-free survival in patients with glioblastoma using routinely collected data | SpringerLink
Efficay Points for Oncology study and background knowlwdge
Thalidomide maintenance treatment increases progression-free but not overall survival in elderly patients with myeloma | Haematologica
Disease-free and overall survival at 3.5 years for neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin and cyclophosphamide, for women with HER2 negative early breast cancer: ARTemis Trial - Annals of
